Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03963739 · ClinicalTrials.gov registry record
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 255
- Enrollment target
NCT03963739: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03963739 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 255 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03963739 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white adenocarcinoma of the prostate survivors before treatment and 6 months after treatment completion.
Primary Outcome
Calculate 95% confidence intervals around the work ability score and the change in the work ability score. A two group t-test will be used to compare changes in the work ability score by race (white, African American), followed by a general linear model to compare changes in work ability with adjustment for demographic, work environment, and other baseline characteristics.
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2019-07-19 |
| Est. Completion | 2025-03-25 |
What the finished NCT03963739 record still lists
NCT03963739 is an observational study that tracks outcomes without assigning an intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT03963739 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03963739 about?
NCT03963739 is a clinical study titled "Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer". The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white...
What is the current status of trial NCT03963739?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2019-07-19. Estimated completion is 2025-03-25.
What interventions are being tested in trial NCT03963739?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT03963739?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI